Get the free weekly funding digest
The new funding rounds, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.
New funding rounds, summarized for you
No login, no app to check — it comes to you
See who's moving and how much in your market
Oxeia Biopharmaceuticals raises over $1.2 million in its first equity crowdfunding campaign, reflecting strong investor interest in its innovative concussion therapy.
Amount Raised
$1.2 Million
Round Type
seed
BostonDescription
Oxeia Biopharmaceuticals announced that its Regulation Crowdfunding campaign has oversubscribed, raising over $1.2 million. This funding will support trials for OXE103, aimed at treating persistent concussion symptoms. The company is extending the campaign to allow more investors to participate. CEO Michael Wyand highlighted early investor interest due to the promising clinical results of their therapy.
Related People
Watching Oxeia Biopharmaceuticals? See every signal — funding, hires, M&A, contracts, sentiment.
Request a demoChoose your plan